Enter Retatrutide Retatrutide is the first triple agonist targeting 3 metabolic receptors at once: GLP-1: Enhances insulin, reduces appetite, slows digestion GIP: Boosts insulin, improves lipid metabolism GCGR: Increases energy expenditure, burns fat GLP-1 activation stimulates insulin secretion from pancreatic -cells, reduces appetite through central pathways, and slows gastric emptying to reduce glucose spikes
Should I take this or NAC? Different approaches
However, evidence of the efficacy of enhanced control of glycemia in preventing neuropathy is stronger in patients with type 1 diabetes than in those with type 2 diabetes (73)
The first week typically marks the beginning of these changes, with the full effect becoming more pronounced in the following weeks
Learn dosing protocols, mechanisms, safety, and research insights.
10.1136/gut.50.3.341 110 SecherA.JelsingJ.BaqueroA